Levels of Circulating Intercellular Adhesion Molecule-1 in Patients with Metastatic Cancer of the Prostate and Benign Prostatic Hyperplasia

By Wolff J.M.   Stephenson R.N.   Chisholm G.D.   Habib F.K.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 339-341

Elsevier

Access to resources Recommend Favorite

Soluble CD44 Molecules in Serum of Patients with Prostate Cancer and Benign Prostatic Hyperplasia

By Jung K.   Lein M.   Weiss S.   Schnorr D.   Henke W.   Loening S.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 627-630

Elsevier

Access to resources Recommend Favorite

Are We Overlooking Stage a Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia with Medical or Minimally Invasive Modalities?

By Kocurek J.N.   Orihuela E.   Neal D.E.   Pow-Sang M.   Warren M.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 4, 1995-07 ,pp. : 153-155

Elsevier

Access to resources Recommend Favorite

Human Papillomavirus in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Patients

By Chen Alice  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 613-617

Springer Publishing Company

Access to resources Recommend Favorite

Voltagegated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells

By                  

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 345-350

Spandidos Publications

Access to resources Recommend Favorite